Article| Volume 24, ISSUE 8, P1675-1683, August 2022

The effect of rapid exome sequencing on downstream health care utilization for infants with suspected genetic disorders in an intensive care unit



      This study aimed to compare downstream utilization of medical services among critically ill infants admitted to intensive care units who received rapid exome sequencing (ES) and those who followed alternative diagnostic testing pathways.


      Using propensity score–weighted regression models including sex, age at admission, and severity indicators, we compared a group of 47 infants who underwent rapid ES with a group of 211 infants who did not receive rapid ES. Utilization and cost indicators were compared between cohorts using negative binomial models for utilization and two-part models for costs.


      After controlling for patients’ sociodemographic and clinical characteristics, we found no statistically significant difference in outpatient visits, hospitalizations, intensive care unit or total length of stay, or length of stay–associated costs between the cohorts at 12- or 26-month follow-up. Similarly, there was no evidence of higher utilization or costs by the ES group when infants who died were removed from the analysis.


      When examining utilization during and beyond the diagnostic trajectory, there is no evidence that ES changes frequency of outpatient visits or use of in-hospital resources in critically ill infants with suspected genetic disorders.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      ACMG Member Login

      Are you an ACMG Member? Sign in for online access.


      Subscribe to Genetics in Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Alam K.
        • Schofield D.
        Economic evaluation of genomic sequencing in the paediatric population: a critical review.
        Eur J Hum Genet. 2018; 26: 1241-1247
        • Clark M.M.
        • Stark Z.
        • Farnaes L.
        • et al.
        Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
        NPJ Genom Med. 2018; 3: 16
        • Elliott A.M.
        • du Souich C.
        • Lehman A.
        • et al.
        RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit—successes and challenges.
        Eur J Pediatr. 2019; 178: 1207-1218
        • Smith H.S.
        • Swint J.M.
        • Lalani S.R.
        • et al.
        Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature.
        Genet Med. 2019; 21: 3-16
        • Malinowski J.
        • Miller D.T.
        • Demmer L.
        • et al.
        Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability.
        Genet Med. 2020; 22: 986-1004
        • Krantz I.D.
        • Medne L.
        • et al.
        • NICUSeq Study Group
        Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial.
        JAMA Pediatr. 2021; 175 (Published correction appears in JAMA Pediatr. 2021;175(12):1295.): 1218-1226
        • Li C.
        • Vandersluis S.
        • Holubowich C.
        • et al.
        Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies.
        Genet Med. 2021; 23: 451-460
        • Yeung A.
        • Tan N.B.
        • Tan T.Y.
        • et al.
        A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients.
        Genet Med. 2020; 22: 1986-1993
        • Schofield D.
        • Rynehart L.
        • Shresthra R.
        • White S.M.
        • Stark Z.
        Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.
        Genet Med. 2019; 21: 2586-2593
        • Stark Z.
        • Schofield D.
        • Martyn M.
        • et al.
        Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
        Genet Med. 2019; 21 (Published correction appears in Genet Med. 2019;21(2):516.): 173-180
        • Sanford Kobayashi E.
        • Waldman B.
        • Engorn B.M.
        • et al.
        Cost efficacy of rapid whole genome sequencing in the pediatric intensive care unit.
        Front Pediatr. 2022; 9: 809536
        • Freed A.S.
        • Clowes Candadai S.V.
        • Sikes M.C.
        • et al.
        The impact of rapid exome sequencing on medical management of critically ill children.
        J Pediatr. 2020; 226: 202-212.e1
        • Meng L.
        • Pammi M.
        • Saronwala A.
        • et al.
        Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management.
        JAMA Pediatr. 2017; 171e173438
        • Sanford E.F.
        • Clark M.M.
        • Farnaes L.
        • et al.
        Rapid whole genome sequencing has clinical utility in children in the PICU.
        Pediatr Crit Care Med. 2019; 20: 1007-1020
        • Wang H.
        • Qian Y.
        • Lu Y.
        • et al.
        Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants.
        NPJ Genom Med. 2020; 5: 20
        • Willig L.K.
        • Petrikin J.E.
        • Smith L.D.
        • et al.
        Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings.
        Lancet Respir Med. 2015; 3: 377-387
        • Kingsmore S.F.
        • Henderson A.
        • Owen M.J.
        • et al.
        Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing.
        NPJ Genom Med. 2020; 5: 49
        • Murphy S.L.
        • Xu J.
        • Kochanek K.D.
        • Arias E.
        Mortality in the United States, 2017.
        NCHS Data Brief. 2018; : 1-8
        • Canadian Institute for Health Information
        Care in Canadian ICUs.
        CIHI, 2016
        • Friedman J.M.
        • Bombard Y.
        • Cornel M.C.
        • et al.
        Genome-wide sequencing in acutely ill infants: genomic medicine’s critical application?.
        Genet Med. 2019; 21: 498-504
        • Kingsmore S.F.
        • Petrikin J.
        • Willig L.K.
        • Guest E.
        Emergency medical genomes: a breakthrough application of precision medicine.
        Genome Med. 2015; 7: 82
        • Carey A.S.
        • Schacht J.P.
        • Umandap C.
        • et al.
        Rapid exome sequencing in PICU patients with new-onset metabolic or neurological disorders.
        Pediatr Res. 2020; 88: 761-768
        • Dimmock D.
        • Caylor S.
        • Waldman B.
        • et al.
        Project Baby Bear: rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care.
        Am J Hum Genet. 2021; 108: 1231-1238
        • Farnaes L.
        • Hildreth A.
        • Sweeney N.M.
        • et al.
        Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization.
        NPJ Genom Med. 2018; 3: 10
        • Stark Z.
        • Lunke S.
        • Brett G.R.
        • et al.
        Meeting the challenges of implementing rapid genomic testing in acute pediatric care.
        Genet Med. 2018; 20: 1554-1563
        • Smith H.S.
        • Swint J.M.
        • Lalani S.R.
        • et al.
        Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions.
        Genet Med. 2020; 22: 1303-1310
      1. BC Children’s & Women’s Hospitals. Provincial Health Services Authority.
      2. Canadian Institute for Health Information. Trends in hospital spending, 2005-2006 to 2018-2019—data tables—series C: average direct cost per patient by selected functional centre. CIHI. Accessed February 17, 2021.

        • Johnston K.M.
        • Gooch K.
        • Korol E.
        • et al.
        The economic burden of prematurity in Canada.
        BMC Pediatr. 2014; 14: 93
        • Rios J.D.
        • Shah P.S.
        • Beltempo M.
        • et al.
        Costs of neonatal intensive care for Canadian infants with preterm birth.
        J Pediatr. 2021; 229: 161-167.e12
        • Wooldridge J.M.
        Econometric Analysis of Cross Section and Panel Data.
        2nd ed. MIT Press, 2010
        • Imbens G.W.
        • Rubin D.B.
        Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction.
        Cambridge University Press, 2015
        • C.M.G.+.Canadian
        Institute for Health Information.
        Date accessed: April 7, 2021
        • Harder V.S.
        • Stuart E.A.
        • Anthony J.C.
        Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research.
        Psychol Methods. 2010; 15: 234-249
        • Hayeems R.Z.
        • Bhawra J.
        • Tsiplova K.
        • et al.
        Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.
        Eur J Hum Genet. 2017; 25: 1303-1312
        • Matas J.L.
        • Agana D.F.G.
        • Germanos G.J.
        • et al.
        Exploring classification of birth defects severity in national hospital discharge databases compared to an active surveillance program.
        Birth Defects Res. 2019; 111: 1343-1355
        • Dorling J.S.
        • Field D.J.
        • Manktelow B.
        Neonatal disease severity scoring systems.
        Arch Dis Child Fetal Neonatal Ed. 2005; 90: F11-F16
        • Hussain S.B.
        • Quittner A.L.
        • Brown M.
        • Li-Rosi A.M.
        Understanding access to genomics in an ethnically diverse south Florida population: a comparison of demographics in odyssey and rapid whole genome sequencing programs.
        J Genet Couns. 2020; 29: 553-561
        • Wojcik M.H.
        • Fraiman Y.S.
        Further considerations on the value of whole-genome sequencing in critically ill infants.
        JAMA Pediatr. 2022; 176: 420-421
        • Kingsmore S.F.
        • Cakici J.A.
        • Clark M.M.
        • et al.
        A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants.
        Am J Hum Genet. 2019; 105: 719-733